TY - JOUR
KW - COVID-19/prevention & control
KW - Humans
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/prevention & control/therapy
KW - Pandemics
KW - SARS-CoV-2
KW - Telemedicine/methods
AU - R. Li
AU - M. Zhao
A1 - 
AD - Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine.; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine.; Shanghai Key Laboratory of Psychotic Disorders.; CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Sciences, Shanghai, China.
BT - Current opinion in psychiatry
C5 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - 4
DO - 10.1097/YCO.0000000000000708
IS - 4
JF - Current opinion in psychiatry
LA - eng
M1 - Journal Article
PB - Wolters Kluwer Health, Inc
PY - 2021
SN - 1473-6578; 0951-7367; 0951-7367
SP - 369
EP - 375
EP - 
T1 - Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic
T2 - Current opinion in psychiatry
TI - Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic
U1 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 33859127
U3 - 10.1097/YCO.0000000000000708
VL - 34
VO - 1473-6578; 0951-7367; 0951-7367
Y1 - 2021
Y2 - Jul 1
ER -